US Patent Issued to ViiV Healthcare UK (NO.5) on March 24 for "Human immunodeficiency virus GP120 binding proteins" (Connecticut, North Carolina Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,911, issued on March 24, was assigned to ViiV Healthcare UK (NO.5) Ltd. (Stevenage, Great Britain).

"Human immunodeficiency virus GP120 binding proteins" was invented by Eric Arnoult (Branford, Conn.), Tiancen Hu (Branford, Conn.), Mark R. Krystal (Branford, Conn.) and James Schawalder (Durham, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antigen binding proteins of the invention bind to Human Immunodeficiency Virus (HIV) envelope protein and are useful in treating and preventing HIV infection. In particular, the antigen binding proteins bind to two different epitopes on HIV envelope surface glycoprotein 120 (gp120): the V3 loop region and t...